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Omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) provide significant health
benefits and this has led to an increased consumption as dietary supplements. Omega-3 fatty acids EPA and DHA
are found in animals, transgenic plants, fungi and many microorganisms but are typically extracted from fatty fish,
putting additional pressures on global fish stocks. As primary producers, many marine microalgae are rich in EPA
(C20:5) and DHA (C22:6) and present a promising source of omega-3 fatty acids. Several heterotrophic microalgae
have been used as biofactories for omega-3 fatty acids commercially, but a strong interest in autotrophic
microalgae has emerged in recent years as microalgae are being developed as biofuel crops. This paper provides
an overview of microalgal biotechnology and production platforms for the development of omega-3 fatty acids
EPA and DHA. It refers to implications in current biotechnological uses of microalgae as aquaculture feed and
future biofuel crops and explores potential applications of metabolic engineering and selective breeding to
accumulate large amounts of omega-3 fatty acids in autotrophic microalgae.
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Polyunsaturated fatty acidsIntroduction
Omega-3 (ω-3) fatty acids are polyunsaturated fatty acids
(PUFAs) and essential components for the growth of
higher eukaryotes [1]. Nutritionally, eicosapentaenoic
acid (EPA, 20:5) and docosahexaenoic acid (DHA, 22:6)
are the most important fatty acids belonging to this
group of bioactive compounds. These long chain omega-
3 fatty acids provide significant health benefits to the
human population, particularly in reducing cardiac dis-
eases such as arrhythmia, stroke and high blood pressure
[2,3]. Additionally, they have been seen to offer benefi-
cial effects to depression, rheumatoid arthritis and
asthma [4-6].
Currently, the principal source of EPA and DHA for
human consumption is marine fatty fish such as salmon,
mullet and mackerel [7,8]. However, global catches have
been in decline since the late 1980s and the number of* Correspondence: p.schenk@uq.edu.au
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distribution, and reproduction in any mediumoverfished stocks has been increasing exponentially since
the 1950s [9,10]. Furthermore, the presence of chemical
contaminants (e.g. mercury) in fish oil can be harmful to
consumers [11,12]. In addition, fish oil is not suitable for
vegetarians and the odour makes it unattractive. There
is a variety of alternative EPA and DHA sources such as
bacteria, fungi, plants and microalgae that are currently
being explored for commercial production. Fungi require
an organic carbon source and typically long growth peri-
ods [13], plants need arable land, have longer growth
times and have no enzymatic activity for producing long
chain PUFAs EPA and DHA, unless genetically modified
[14]. Microalgae are the initial EPA and DHA producers
in the marine food chain and can naturally grow fast
under a variety of autotrophic, mixotrophic and hetero-
trophic culture conditions with high long chain ω-3 fatty
acid production potential [15]. Autotrophic and mixo-
trophic microalgae fix atmospheric carbon dioxide dur-
ing photosynthesis, can potentially grow on non-arable
land and have short harvesting times [16,17]. A compari-
son shows that microalgae can reach much higher EPAentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Comparison of EPA and DHA fatty acid contents
as percentage from total lipids in examples of bacteria,
fungi, fish, transgenic plants and microalgae
Organism % EPA and/or DHA
production
Reference
Bacteria
Shewanella putrefaciens 40.0 EPA [21]
Alteromonas putrefaciens 24.0 EPA [22]
Pneumatophorus japonicus 36.3 EPA [23]
Photobacterium 4.6 EPA [24]
Fungi
Thraustochytrium aureum 62.9 EPA+DHA [1]
Mortierella 20.0 EPA [25]
Mortierella 13.0 EPA [26]
Pythium 12.0 EPA [27]
Pythium irregulare 8.2 EPA [28]
Fish
Merluccius productus 34.99 EPA+DHA [29]
Theragra chalcogramma 41.35 EPA+DHA [29]
Hypomesus pretiosus 33.61 EPA+DHA [29]
Sebastes pinniger 29.8 EPA+DHA [29]
Oncorhynchus gorbusha 27.5 EPA+DHA [29]
Mallotus villosus 17.8 EPA+DHA [29]
Sardinops sagax 44.08 EPA+DHA [29]
Clupea harengus pallasi 17.32 EPA+DHA [29]
Plant (transgenic)
Soybean 20.0 EPA [30]
Brassica carinata 25.0 EPA [31]
Nicotiana benthamiana 26.0 EPA [32]
Microalgae
Nannochloropsis sp. 26.7 EPA+DHA [33]
Nannochloropsis oceanica 23.4 EPA [34]
Nannochloropsis salina ~28 EPA [35]
Pinguiococcus pyrenoidosus 22.03 EPA+DHA [36]
Thraustochytrium sp. 45.1 EPA+DHA [37]
Chlorella minutissima 39.9 EPA [38]
Dunaliella salina 21.4 EPA [39]
Pavlova viridis 36.0 EPA+DHA [40]
Pavlova lutheri 27.7 EPA+DHA [41]
Pavlova lutheri 41.5 EPA+DHA [42]
Isocrysis galbana ~28.0 EPA+DHA [43]
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other possible sources (Table 1). In particular hetero-
trophic microalgae are well established as an alternative
source of DHA and are added to infant milk formula or
other food [18]. Other microalgal products are used as
food additives, animal feed (including aquaculture), vita-
mins, pigments, pharmaceutical compounds, cosmetics
and potentially as a biofuel source [17,19,20]. The devel-
opment of an efficient large-scale cultivation system for
the commercial production of EPA and DHA would ad-
dress a major global need. Here, we review the potential
of autotrophic eukaryotic microalgae as biofactories for
large-scale production of omega-3 fatty acids.
Microalgae in aquatic food chains: the initial
omega-3 producers
Microalgae are by far the most abundant primary produ-
cers that can be found in most aquatic systems, photo-
synthetically converting light energy and carbon dioxide
(CO2) into biomass such as carbohydrates [44], proteins
[45] and lipids [46]. Under high nutrient supply (eu-
trophic conditions), algae blooms commonly occur as
microalgal cell density drastically increases [47]. During
microalgal blooms the limitation of nutrients or light
halters the increase of biomass. If nutrients, but not
light, are limiting, this leads to the accumulation of
photosynthetic bioproducts such as lipids and carbohy-
drates. These serve as storage products in order to sur-
vive the stressful growth limiting conditions, after which
a large number of cells die [47,48]. Algal biomass is sub-
sequently degraded by microorganisms, consuming large
amounts of oxygen. As a result an anaerobic zone in the
water is formed (Figure 1). In extreme cases, this can
lead to anaerobiosis of the entire water body, causing
the death of plants and animals in the waterway; inter-
estingly this process is also believed to have been the key
factor for large-scale oceanic anoxic events that led to
fossil mineral oil deposition [17].
Importantly, microalgae are also the primary produ-
cers of EPA and DHA that are eventually accumulated
through the various trophic levels. Changes in micro-
algal lipid content are carried on up the food chain
(Figure 2), impacting the growth and dietary make-up
of zooplankton, crustacean larvae, mollusc and some
fish [49]. This subsequently affects the accumulation
of EPA and DHA fatty acids in higher organisms and
humans. Consequently, lipid profiles in microalgae play
a vital role in maintaining the integrity of the world’s
aquatic food webs.
The nutritional importance of microalgae and EPA
content in aquaculture
Microalgae are essential to the aquaculture industry
which has grown substantially over the last 10 years[50,51]. The successful cultivation of oysters, scallops
and mussels is dependent on the ω-3 fatty acids from
microalgal feedstock. The polyunsaturated omega-3
fatty acids EPA and DHA derived from microalgae
(e.g. Isochrysis, Tetraselmis, Chaetoceros, Thalassiosira,
Nannochloropsis) are also known to be essential for
OLIGOTROPHIC                               MESOTROPHIC                                 EUTROPHIC 
Figure 1 Algal blooms in eutrophic aquatic systems use up nutrients and compete for light. If nutrients become limiting first, microalgae
may accumulate large amounts of lipids and/or carbohydrates as a survival strategy. The decay of organic matter by bacteria uses up oxygen
causing localized anaerobiosis zones. These zones (here shown as grey areas) are present in all aquatic systems but occur at much deeper levels
under mesotrophic or oligotrophic conditions. Photosynthetic microalgae require polar polyunsaturated lipids in particular for membrane where
fluidity is critical, while most storage lipid occurs in the form of lipid bodies containing triacylglycerides. These typically vary in their composition
and typically contain a mixture of saturated and unsaturated fatty acids for storage.
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Prior research on the scallop Pecten maximus has
shown a direct relationship between the fatty acid pro-
file of female gonads and the fatty acid composition of
the eggs [54]. The increase of EPA and DHA from an
algal diet significantly increased the concentration of
fatty acids in the digestive gland (78%) of scallops as
well as the female (57%) and male gonads (51%). It
appears that dietary lipids are stored in the digestive
gland and are later transferred to the developing female
gonad. These dietary lipids are then incorporated into
the eggs and can significantly improve their quality.Figure 2 Microalgae are the primary food source of essentially all maThis in turn improves the hatching rate of eggs and
hatching rates have been linked to high contents of
EPA and DHA [53]. Aside from bivalve culture, micro-
algae are also used as food additives to improve the
flesh color of salmon [55], as well as inducing a range
of other biological activities such as survival and resist-
ance [19].
The selection of suitable microalgae species for aqua-
culture is very important. Firstly, a candidate species
must be adaptable to mass culture with high growth
rates and lipid content[34,56]. Furthermore, it must tol-
erate moderate fluctuations of temperature, light andrine and freshwater food chains.
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ture must also have the appropriate size for ingestion
(e.g. from 1 to 15 μm for filter feeders; 10 to 100 μm for
grazers) and be readily digestible [56]. Finally, they must
possess a suitably high lipid composition with long chain
polyunsaturated fatty acids and be free of toxins for
target culture species [34,56]. Selection of the suitable
microalgal diet is of paramount importance to aquacul-
ture hatchery and nursery success [58]. At present, the
most widely cultured species for aquaculture hatcheries
and nurseries include Chaetoceros calcitrans, Isochrysis
galbana, Pavlova lutheri, Pseudoisochrysis paradoxa,
Tetraselmis suecica and Skeletonema costatum. Other
genera include Spirulina, Dunaliella, Chlorella, Thalas-
siosira, Isochrysis and Nannochloropsis [49].
Health benefits of microalgal omega-3 fatty acids
Omega-3 fatty acids represent an important structural
component of human cell membranes, particularly neur-
onal cells [59]. The consumption of EPA and DHA sup-
plements has been shown to prevent cardiovascular,
nervous system and inflammatory conditions [60]. With
regards to cardiovascular health, regular consumption of
ω-3 fatty acids can help reduce the risk of hypertension,
thrombosis, myocardial infarction and cardiac arrhyth-
mias [61]. This occurs because ω-3 fatty acids increase
the high-density lipoprotein/low-density lipoprotein
(HDL/LDL) ratio and decrease the total cholesterol/
HDL ratio [61]. In addition to cardiovascular benefits,
omega-3 fatty acids have also demonstrated positive
effects on brain function and the nervous system[62]. In
pregnant women, the adequate intake of EPA and DHA
is crucial for healthy development of the fetal brain [63].
In infants, arachidonic acid (ARA), an omega-6 fatty
acid, and DHA are also required for normal growth and
functional development [64]. Interestingly, increased
consumption of DHA may also diminish the severity of
depression [65]. Immuno-modulatory effects have been
observed when ω-3 fatty acids were used in the treat-
ment of inflammatory conditions such as rheumatoid
arthritis, Crohn’s disease, ulcerative colitis, psoriasis,
asthma, lupus and cystic fibrosis [66,67]. Children
ingesting fish oil more than once a week had a lower
probability of suffering from asthma [68]. Increasing the
levels of DHA and EPA in patients with rheumatoid
arthritis and ulcerative colitis has also been found to re-
duce pain and improve conditions, although the modes
of operation are unclear at this point [69,70].
There is currently a large demand for microalgae in
the nutraceutical and pharmaceutical industry due to
their health-promoting effects. Microalgal-derived
PUFA, such as ARA and DHA are added as fortifica-
tions to infant formulae—an industry that is worth $10
billion per annum alone. To date, microalgal extractscan be found in many face and skin care products, e.g.
anti-aging cream, refreshing or regenerative care pro-
ducts, sun cream, emollient and anti-irritant in peelers
[19]. Dermochlorella is actually extracted from Chlor-
ella vulgaris, which can stimulate collagen synthesis in
skin supporting tissue regeneration and wrinkle reduc-
tion [71]. Protulines is a protein-rich extract from
Arthrospira (Spirulina), which helps combat early skin
aging, exerting a tightening effect and preventing
wrinkle formation [72].
Omega-3 fatty acid production in microalgae
Microalgae produce a variety of compounds to help in
the adaptation and survival of different environmental
conditions. Many marine microalgal strains have oil con-
tents of between 10–50%, (w/w) and produce a high per-
centage of total lipids (up to 30–70% of dry weight) [1].
The accumulation of fatty acids is closely linked to
microalgal growth stages, functioning as an energy
stockpile during unfavourable conditions or cell division.
Omega-3 is accumulated due to its high energy content,
as well as the good flow properties crucial for cellular
functions [73,74]. To date, the ω-3 fatty acid content
of numerous microalgae strains have been studied.
Strains from the genera Phaeodactylum, Nannochloropsis,
Thraustochytrium and Schizochytrium have demonstrated
high accumulation of EPA and/or DHA. Phaeodactylum
tricornutum [38] and Nannochloropsis sp. [75] demon-
strated an EPA content of up to 39% of total fatty acids,
while strains such as Thraustochytrium [76] and Schizo-
chytrium limacinum [77] contained a DHA percentage of
between 30–40% of total fatty acids when grown hetero-
trophically. High biomass and commercially acceptable
EPA and DHA productivities are achieved with microal-
gae grown in media with optimized carbon and nitrogen
concentrations and controlled pH and temperature con-
ditions [78]. High oil production, including DHA from
Schizochytrium (50% w/w), can be obtained as a result of
high growth rate by controlling of nutrients such as glu-
cose, nitrogen, sodium and some other environmental
factors, such as oxygen concentrations as well as temper-
ature and pH, achieving high cell densities and DHA
productivities [1].
Induction of omega-3 production in autotrophic
microalgae
An increase in microalgal lipid content can be induced by
a sudden change of growth conditions. The accumulation
of starch and/or lipids reserves is considered a survival
mechanism in response to growth-limiting stresses [17],
such as UV radiation [79], temperature [80] and shock or
nutrient deprivation [81,82], as long as light conditions
are present that still allow efficient photosynthesis. For ex-
ample, during nutritional deprivation (e.g. nitrogen) and
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ine or brackish microalgae is put on hold and cells begin
to accumulate lipids [83], leading to a 2–3 fold increase
in lipid content. Both total lipid and omega-3 fatty acid
production can be adjusted by varying growth condi-
tions. The diatom Phaeodactylum tricornutum can be
induced to increase its lipid level from 81.2 mg/g of
culture dry weight to 168.5 mg/g dry weight [38]. Simi-
larly, Nannochloropsis sp. [84] and Dunaliella sp. [85]
can achieve a total lipid content of up to 47% and
60% of dry ash weight by modifying the light intensity,
temperature and salinity levels. Lipid abundance has
also been shown to increase due to anaerobic sulphur
deprivation [86] or the addition of extra nutrients [87].
Omega-3 fatty acid biosynthesis can be stimulated by a
number of environmental stresses, such as low
temperature, change of salinity or UV radiation. For ex-
ample, Pavlova lutheri increased its relative EPA content
from 20.3 to 30.3 M% when the culture temperature was
reduced to 15°C [88]. Similarly, Phaeodactylum tricornu-
tum had a higher EPA content when the temperature
was shifted from 25°C to 10°C for 12 h [89]. An increase
in PUFAs is expected as these fatty acids have good flow
properties and would be predominately used in the cell
membrane to maintain fluidity during low temperatures.
Salinity may also regulate PUFA biosynthesis, although
not in a consistent manner. For example, Crythecodi-
nium cohnii ATCC 30556 increased its total DHA con-
tent up to 56.9% of total fatty acids when cultured in
9 g/L NaCl. Other treatments that cause the generation
of reactive oxygen species and lipid peroxidation also
result in higher PUFA contents. For example, Phaeo-
dactylum tricornutum increased its EPA content up to
19.84% when stressed with UV light [90]. Some of the
increased PUFAs are used to repair membrane damage
but as PUFAs contain many double bonds, these also
act as an antioxidant by scavenging free radicals.
Metabolic engineering of microalgae for higher
omega-3 contents
Apart for external stresses, metabolic engineering is an-
other promising approach to increase the production of
fatty acids in microalgae (for a recent review see Schuh-
mann et al. [91]). Genes encoding key enzymes involved
in the fatty acid biosynthesis have been identified in
Ostreococcus tauri [92], Thalassiosira pseudonana [93-95],
Phaeodactylum tricornutum [96,97] and in particular the
model organism Chlamydomonas reinhardtii [98]. At
present, the mechanisms involved in the fatty acid biosyn-
thetic pathways in microalgae have not been extensively
studied and most information has been gathered from
studies on plant metabolism. Briefly, de novo fatty acid
synthesis occurs in the chloroplast and involves the carb-
oxylation and condensation of acetyl-CoA to malonyl-CoA,with further elongation reactions occurring with malonyl
ACP as substrate to create long chain fatty acids. Long
chain fatty acids are transferred to glycerol-3-phosphate to
form triacylglycerol (TAG) via the metabolic intermediate
phosphatidic acid in the endoplasmic reticulum [99]. Syn-
thesis of ω-3 fatty acids occurs via the elongation and desat-
uration of long chain fatty acids (Figure 3).
Work has been performed to create recombinant
sources of ω-3 fatty acids in a variety of systems with
some success [101,102]. Canola (Brassica napus) seeds
have been produced which overexpress the B. napus
Δ15 desaturase, as well as the Δ6 and Δ12 desaturases
from the commercially grown fungus Mortierella alpina
to synthesize the ω-3 fatty acid stearidonic acid (SDA)
[14]. It may be possible in the future to produce ω-3
fatty acids in microalgae in much larger quantities by
regulating the expression of similar enzymes. A promis-
ing cisgenic approach for microalgae maybe to increase
EPA or DHA production by overexpressing at least some
of their native elongases and desaturases. It may be ne-
cessary to use promoters inducible by external stimuli
rather than constitutive promoters that may interfere
with normal cell function and growth. Another, yet
unexplored option may lie in the inhibition of PUFA
degradation. β-oxidation of fatty acids occurs in the
peroxisomes but before PUFAs can be metabolized,
saturases are required to fill in the double bonds.
Mutations in one or several saturases may result in
less efficient β-oxidation of PUFA and a higher per-
centage of these fatty acids. However, at present the
mechanism behind the selection and storage of fatty
acids for triacylglycerol production remains unclear.Extraction and purification of omega-3 fatty acids
from microalgal biomass
Figure 4 summarizes an integrated system for the large-
scale production of microalgal bio-products. A microal-
gae strain is cultivated to increase cell density using
photobioreactors, open ponds, race ways or hybrid sys-
tems. Algal cells are separated from culture media by fil-
tration, flocculation or centrifugation, followed by drying
to improve extraction [1]. Lipid extraction is then com-
monly performed using a non-water miscible organic
solvent. A typical extraction protocol in small scale is
often based on the method of Bligh and Dyer [103],
which uses a solvent mixtures made of methanol/
chloroform for the cell disruption and lipid extraction.
Larger scale extraction is typically carried out with hexane
as a solvent. Subsequently, unsaturated fatty acids are
separated from the total lipids by fractional (molecular)
distillation or winterization, whereby oil temperature is
reduced to precipitate the more saturated lipids. Further
processing to improve the quality, shelf-life and quantity of
Figure 3 Conventional Δ6-pathway for biosynthesis of EPA and
DHA polyunsaturated fatty acids [100].
Figure 4 Examples of a bioprocess production chain in a
microalgal biorefinery. Apart from omega-3 fatty acids (ω-3), the
product portfolio includes biodiesel and protein-rich animal feed
from the remaining biomass.
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polishing and antioxidant addition [1,104] (Table 2).
Efforts have been made to use lipases, hydrolysis and
esterification processes to selectively enrich PUFAs. The
main application of lipases on PUFAs is the generation
of non-natural esters of these products for use as
pharmaceutical products or other synthetic bioactive
compounds or their precursors [1]. The effectiveness ofharvesting and extraction techniques depends on the
microalgal strain's physical characteristics (e.g. cell size
and cell wall properties) and the use of the end product.
In aquaculture, microalgae are used as a fresh product
or as dry pellets which preserve the nutritional content
of microalgae [57,58,111]. In this case, microalgal bio-
mass is first de-watered either by filtration, dissolved air
flotation, flocculation or sedimentation and then dried
to form pellets or directly administrated to livestock
[111]. When produced for the pharmaceutical industry,
further extraction and purification processes are
required. Currently, methods such as supercritical fluid
extraction, winterization and fractional (molecular) dis-
tillation are used for the extraction and purification of
PUFA from microalgae [112,113] (Table 2)
Omega-3 fatty acid production: a biorefinery
approach
The natural capacity of microalgae to produce multiple
products, (e.g. oils, proteins and carbohydrates) has
Table 2 Summary of PUFA enrichment processes
Method Procedure
Molecular distillation (Fractional distillation) Purification of fatty acid esters in a vacuum system based on the different boiling points of different
fatty acids [105].
Molecular sieves Separation via membrane permeability and selectivity [106].
PUFA transformations Esterification of PUFA and free fatty acids to produce esters (ethyl-, glyceryl-, sugar-, other).
Inter-esterification to enrich lowly unsaturated fatty acids with PUFA [107].
Super Critical Fluid Extraction Optimization of lipid solubility and fractionation in supercritical CO2 [108].
Urea complexation Solubilization of fatty acids, adding urea and ethanol to saturation point exposing it to heat.
Recovery of product by filtration [109].
Winterization Temperature reduction to render more saturated fats insoluble [110].
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processing. Akin to the petrochemical industry, where
crude oil is processed to yield petroleum and a range of
other chemicals, microalgae can be processed to produce
a range of bioproducts. Different industries are able to
use different algal products. For instance, the pharma-
ceutical and nutraceutical industries use high value bio-
active products such as ω-3 fatty acids and carotenoids;
the transport industry can use fatty acids from TAG for
biodiesel, the chemical industry can use products such
as glycerine, while the majority of the biomass can be
used by agriculture and aquaculture as animal feed
[114,115]. Additional processes that address nutrient re-
cycling and carbon sequestration can be used by anaer-
obic digestion of wet biomass and pyrolysis for the
production of biochar.
Undoubtedly, the biggest interest in microalgal use is
for biodiesel production. It potentially represents a more
sustainable alternative to fossil fuels as microalgal pro-
duction facilities do not need to compete for arable land
or freshwater. Furthermore, in comparison to land
plants, 10–400 times more energy per acre can poten-
tially be produced from microalgae. Although there has
been considerable interest and research over the past
years into microalgal biofuel production [83], no com-
mercial enterprise has successfully established itself as a
supplier of autotrophically derived algal biofuels for any
duration. Nevertheless, decreasing fossil fuel reserves
and increasing fuel costs continue to drive research tar-
geted towards economically viable production of micro-
algal biodiesel, with the level of improvement necessary
now appearing attainable [15,17]. There is confidence
among companies producing microalgae that the pro-
duction of a high value product, such as omega-3 from
microalgae, will further assist in the establishment of the
microalgae industry. Several companies have (at least
temporarily) shifted their focus from algal biodiesel pro-
duction, to high value products such as omega-3 and
protein-rich biomass as animal feed (e.g. Aurora Algae,
MBD, Cellana).Conclusions
Global fish stocks are declining and cannot provide a sus-
tainable source of omega-3 fatty acids. Heterotrophic
microalgae have been used for the production of omega-3
fatty acids, in particular DHA. However, as the primary
producers of PUFAs, the use of autotrophic microalgae
for large-scale production of omega-3 fatty acids has re-
cently attracted a lot of interest. Autotrophic microalgae
do not require an organic carbon source and hence may
avoid the problems faced for heterotrophic cultures that
can easily get contaminated with other microorganisms.
In a biorefinery concept, omega-3 fatty acids can be sepa-
rated from microalgal lipids which would be widely used
for biodiesel production, while biomass can find uses as
valuable protein-rich animal feed which could free up ar-
able land for food production. If carried out at a large
scale this would address three major areas of importance:
human health, transportable energy and food security.
Over the past decade, algae biotechnology has grown
steadily into a global industry with increasing numbers of
entrepreneurs attempting to utilize its biochemical diversity
for a wide array of applications. At present, achieving eco-
nomically viable production of microalgal lipids is still a
major challenge, but strong potential stems from the fact
that these microbial cell factories have not been domesti-
cated and are not as well studied compared to agricultural
crops [102]. Indeed, of approximately 40,000 algal species,
only a few thousand strains are kept in collections, a few
hundred are investigated for chemical content and approxi-
mately half a dozen are cultivated in industrial quantities.
Therefore, continued isolation and screening of microalgae
is required, as well as more in depth studies into algal
physiology, biochemistry and genetics. Meanwhile the pro-
cesses for algae cultivation, harvesting and oil extraction
need to be further improved in efficiency and costs. As
omega-3 fatty acids are one of the most valuable products
from microalgae, they are likely to be the “game-changer”
towards large-scale economical microalgae cultivation that
will catalyze the production of other important algal
bioproducts.
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